mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

mTORC1 and DNA-PKcs as Novel Molecular Determinants of Sensitivity to Chk1 Inhibition

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity

Scientific Reports
Multidisciplinary
2016English

Simultaneous Exposure of Transformed Cells to SRC Family Inhibitors and CHK1 Inhibitors Causes Cell Death

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2011English

Chk1 and Mps1 Jointly Regulate Correction of Merotelic Kinetochore Attachments

Journal of Cell Science
Cell Biology
2013English

γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells

Cancer Discovery
Oncology
2015English

Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional P53

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Analysis of Rad3 and Chk1 Protein Kinases Defines Different Checkpoint Responses

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
1998English

Ciclopirox Activates ATR-Chk1 Signaling Pathway Leading to Cdc25A Protein Degradation

Genes and Cancer
Cancer ResearchGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy